Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Drug trial GPs are set to lose £30k

Dr Barry Silvert is warning many GPs could lose £30,000 a year in clinical research contracts because primary care organisations are 'muscling in' on approval for drug trials.

Dr Silvert, chair of the British Association of Clinical Research in Primary Care, set up last month, said PCOs were adding extra bureaucracy to the approvals process. 'PCTs do not have a role in making decisions as to whether a trial is ethical or not,' he said.

'It's already cheaper for the pharmaceutical industry to work in eastern Europe and this could be the final straw.'

Around 700 GPs stood to lose between £20,000 to £30,000 a year if the trials went overseas, added Dr Silvert, a GP in Bolton.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say